Olema Pharmaceuticals, Inc. Share Price

Olema Pharmaceuticals, Inc. Share Price

NASDAQ: OLMA | Small Cap
$7.00
-$0.34 (-4.64%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Olema Pharmaceuticals, Inc. Stock Performance

Open
$7.22
Prev. Close
$7.33
Circuit Range
N/A
Day Range
$6.92 - $7.41
Year Range
$6.24 - $36.15
Volume
45,990
Average Traded
$7.02

Olema Pharmaceuticals, Inc. Share Price Today

As of 31 October 2026, Olema Pharmaceuticals, Inc.'s share price is $7.00. The stock opened at $7.22, compared to its previous close of $7.33. During today's trading session, Olema Pharmaceuticals, Inc.'s share price traded between $6.92 and $7.41, with an average price of $7.17. Over the past 52 weeks, the stock has recorded a high of $36.15 and a low of $6.24. In terms of performance, Olema Pharmaceuticals, Inc.'s share price has declined by 51.56% over the last six months and is down 22.02% on a year-on-year basis.

Olema Pharmaceuticals, Inc. Share Price Chart

Line chart of the Olema Pharmaceuticals, Inc. price trend over the selected period. The price fell overall, ranging from 6.91 to 7.12, ending at 7.00.
$6.92$7.41
L
Show Current Price
H

Olema Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$608.61M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.34
Revenue (TTM)
$0.00
Return On Equity (TTM)
-47.51%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-49.69%

Olema Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$42.22-$46.06-$53.09-$63.20
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-9.10%-15.26%-19.04%

Olema Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$104.79-$96.66-$129.47-$162.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A7.76%-33.94%-25.47%

About Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Olema Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$8.64
$6.99
-19.42%
Sep 2026
$10.40
$8.68
-19.53%
Aug 2026
$11.39
$10.78
-5.69%
Jul 2026
$12.59
$11.43
-8.78%
Jun 2026
$13.08
$12.53
-5.08%
May 2026
$14.38
$13.20
-8.59%
Apr 2026
$15.14
$14.44
-3.15%
Mar 2026
$23.72
$14.91
-38.43%
Feb 2026
$24.16
$24.21
-5.81%
Jan 2026
$24.82
$25.71
+2.72%
Dec 2025
$27.72
$25.03
-11.74%
Nov 2025
$9.04
$28.36
+216.16%

OLMA Share Price FAQs